Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · TELOS CORP (TLS)

Telos CEO John Wood returns from medical leave, resumes full duties May 28

Neutral Impact 3 of 5 leadership Written later

Telos Corporation said CEO and Chairman John B. Wood returned from medical leave and resumed his full duties effective May 28, 2026. Interim arrangements announced April 29, 2026 ended, and the executives who had covered for him return to their regular roles.

Key points

  • John B. Wood resumed full duties as President, CEO and Chairman effective May 28, 2026
  • Interim arrangements announced April 29, 2026 terminated
  • Mark Griffin, Mark Bendza, Hutch Robbins and Fred Schaufeld stopped their interim roles and continue in regular positions
  • No compensatory arrangements were entered into or modified in connection with Wood's return

The filing

CompanyTELOS CORP (TLS)
Form8-K, current report
Filed with the SECMay 28, 2026, 4:04 PM ET
Accession number0000320121-26-000027

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 28, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.